Viewing nowARB Tablets (Losartan Potassium)
Losartan Potassium 50mg
Tablet · Prescription medication
Samjin Pharmaceutical Co., Ltd.

MFDS item code 200600349 · Notified 2006.02.08 · Insurance code 647801640
Treatment of hypertension and kidney disease in patients with type 2 diabetes accompanied by hypertension
This medication is used to treat hypertension. It is also helpful in treating nephropathy in patients with hypertension and type 2 diabetes. Therefore, it is effectively used to control blood pressure and protect kidney health.
This medicine may be taken with or without food, but it is recommended that it be taken at the same time every day. Adults with hypertension: The recommended initial and maintenance dose is 50 mg of losartan potassium orally once daily. The maximum blood pressure-lowering effect occurs 3 ∼ 6 weeks after starting treatment. If the treatment effect is insufficient, the same dose may be divided and administered orally twice daily, or, if necessary, the dose may be increased to 100 mg once daily. If blood pressure is not controlled with this medicine alone, it may be administered in combination with another antihypertensive agent (e.g., a low-dose diuretic). An additive effect has been observed with concomitant administration of hydrochlorothiazide. Nephropathy in patients with type 2 diabetes and hypertension: The usual adult dose is 50 mg of this medicine once daily. The dose may be increased to 100 mg once daily depending on blood pressure. However, an initial dose of 25 mg is recommended for patients at risk of excessive blood pressure reduction. This medicine may be administered concomitantly with insulin and commonly used antidiabetic agents (e.g., sulfonylureas, glitazones, and glucosidase inhibitors). No adjustment of the initial dose is necessary in elderly patients aged 75 years or younger. For elderly patients over 75 years of age, an initial dose of 25 mg of this medicine once daily is recommended. Creatinine clearance 20 ∼ 50 mL/min: No adjustment of the initial dose is necessary. Creatinine clearance < 20 mL/min and patients on dialysis: An initial dose of 25 mg of this medicine once daily is recommended. For patients who may have reduced effective circulating blood volume (e.g., patients receiving diuretic therapy), an initial dose of 25 mg of this medicine once daily is recommended (see the Precautions for Use section). A lower dose should be considered in patients with a history of hepatic impairment. Do not administer to patients with severe hepatic impairment.
Children and adolescents aged 6 years and older who weigh 20 kg or more but less than 50 kg and are able to swallow tablets: The recommended dose is 25 mg once daily. The dose may be increased to a maximum of 50mg once daily depending on the patient's blood pressure response. Children and adolescents aged 6 years and older who weigh 50 kg or more: The usual recommended dose is 50 mg once daily. The dose may be increased to a maximum of 100 mg once daily depending on the patient's blood pressure response. Children under 6 years of age: Not recommended. Pediatric patients with a glomerular filtration rate of less than 30 mL/min/1.73㎡: Not recommended. Pediatric patients with hepatic impairment: Not recommended.
This drug can cause serious harm to the fetus if taken during pregnancy, particularly in the second and third trimesters, and should be discontinued immediately upon confirmation of pregnancy. It can affect kidney development in the fetus, potentially reducing amniotic fluid, which may increase the risk of lung development issues and skeletal malformations. Severe side effects such as impaired cranial formation, renal failure, hypotension, or anuria may occur in newborns, so it should never be used during pregnancy. This drug should not be administered to individuals with hypersensitivity, severe liver impairment, hereditary angioedema, or primary hyperaldosteronism, among others. Patients with genetic metabolic disorders such as galactose intolerance or lactase deficiency should also refrain from taking this medication. Particular caution is needed for diabetic patients or those with moderate to severe renal impairment, as the risk may increase when combined with certain medications. Elderly patients, those with hyperkalemia, and those with mild to moderate liver impairment should be administered with caution, and cardiovascular patients should be vigilant due to the risk of myocardial infarction or stroke caused by blood pressure reduction. Patients with reduced blood volume or renal artery stenosis should also use this drug carefully. While this medication generally has good tolerability, adverse reactions such as dizziness, headache, muscle pain, dyspepsia, cough, edema, and others may occur. Rarely, serious side effects such as angioedema, liver dysfunction, rhabdomyolysis, and hyperkalemia can occur, so if any abnormal symptoms appear, immediate consultation with a healthcare professional is necessary. Patients with liver dysfunction may have increased blood concentration of this drug, so starting with a smaller dose is advisable. For patients with impaired kidney function, regular blood tests and monitoring of kidney function are required due to the risk of renal failure and hyperkalemia. If symptoms of too low blood pressure appear, discontinue use and seek appropriate medical attention. This medication may interact with other antihypertensives or certain diuretics and potassium-sparing agents, so it should be taken after consulting with a physician. Grapefruit juice may reduce the effectiveness of this medication, so it is best to avoid it during treatment. This medication is not recommended for breastfeeding women, and it is preferable to discontinue breastfeeding while taking it. It is not administered to children under 6 years of age or those with severe renal impairment due to insufficient safety data. During treatment, dizziness or drowsiness may occur, so caution is advised while driving or operating machinery. In case of overdose, symptoms such as hypotension and cardiac arrhythmias may appear, requiring immediate medical attention, and treatment should be tailored to the symptoms. This medication should be kept out of the reach of children and should not be transferred to other containers.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly sealed container to prevent exposure to air and moisture. It is recommended to maintain a storage temperature between 1 and 30 degrees Celsius.
White oval film-coated tablet
30 tablets per bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowLosartan Potassium 50mg
Tablet · Prescription medication
Samjin Pharmaceutical Co., Ltd.

Losartan Potassium 50mg
Tablet · Prescription medication
DaeWon Pharmaceutical Co., Ltd.

Losartan Potassium 50mg
Tablet · Prescription medication
Korea United Pharm, Co., Ltd.

Losartan Potassium 50mg
Tablet · Prescription medication
HK Inno.N Co., Ltd.

Losartan Potassium 50mg
Tablet · Prescription medication
IYON Pharmaceuticals Co., Ltd.
Losartan Potassium
Prescription medication
JW ShinYak Co., Ltd.

Losartan Potassium 50mg
Tablet · Prescription medication
Kukje Pharmaceutical Co., Ltd.

Losartan Potassium 50mg
Tablet · Prescription medication
Celltrion Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.